XIII International AIDS Conference Report #3

Lisa Garbus, MPP, HIV InSite Policy and International Editor
July 11, 2000

Position of the South African Government on Access to Pharmaceuticals

The South African Dept. of Health released this statement on July 11, 2000:

  • Our country is part of the fight for an international dispensation that ensures greater access to ALL drugs for people in the developing world and the economically marginalised in the North. South Africa's engagement with the pharmaceutical industry on this front is well known. In our support for this international effort we include the availability of all effective treatment to deal with the epidemic of HIV and AIDS.

  • The South African government is encouraged by the growing support for such interventions as parallel importing, compulsory licensing and local manufacturing, and we support these initiatives fully.

    We reiterate our government's often stated view that in exploring these options, the South African government will respect international agreements that it is signatory to, including TRIPS.

    We believe that these interventions would improve the capacity of developing nations to ensure greater access to drugs.

  • We recognise the benefits that accrue to those who can afford the use of antiretrovirals, but stress that in our context, this is far from reality. The pharmaceutical manufacturers must confront this reality. The ball is in their court.

  • We also recognise that the cost of these drugs is not the only deterrent to their use. We need to systematically invest in and build our health infrastructures so that advances in drug treatment can be made available to those who need it.

    This is the challenge to all peoples and governments of the world, particularly those in the developed world.

    Certainly, lower prices of drugs would enable our government to redirect some resources to infrastructure building.

  • We also urge the pharmaceutical industry, development agencies, government and NGOs to work together and invest in technologies that would address the burden of disease in developing countries.

  • We support the Revised Drug Strategy resolution adopted by the World Health Assembly in 1999, and urge for its speediest and full implementation. The central feature of this resolution is to improve access to essential drugs in developing countries.

  • In 1997 the South African government enacted an amendment to its Medicines Act. A key element of this was to provide for such measures as parallel importing and greater use of generics in our market.

    This piece of legislation, however, could not be implemented to date because of a court interdict initiated by the PMA (SA) (Pharmaceutical Manufacturers Association).

    The PMA represents an association of largely North American and West European pharmaceutical multinationals in South Africa.

    We expect this court case to proceed during the latter part of this year.

  • We have noted the recent offers by pharmaceutical companies to begin dialogue with a view to improving access to antiretrovirals. We reiterate the views of SADC and African Ministers as expressed in press releases in Geneva in May 2000 that these discussions must extend beyond the narrow issue of antiretrovirals.

    We support this dialogue within the framework of the active participation of representatives of the beneficiary countries in this dialogue.

    11 July 2000

    Issued by Dr Ayanda Ntsaluba, Director-General, Department of Health, South Africa

    For enquiries, contact Faizel Dawjee (083) 254-2923.

    Debate on Treatment to Prevent Mother-to-Child Transmission without Treatment for the Mother

    This session focused on the following statement:

    NGOs should advocate against treatment to prevent mother-to-child transmission without treatment for the mother.

    Effective treatments (nevirapine, AZT) exist to prevent HIV transmission from mother to infant. However, many AIDS professionals and activists believe that it is morally indefensible to argue for treatment of the infant when there is no treatment for the mother. Others worry about who will care for the HIV-negative children when their HIV-positive mothers die. Some are debating whether NGOs should advocate for treatment of the infant only if there is treatment for the mother as well.

    Ms. Caroline Maposhere, of Women of Choice and Voice, a Zimbabwean NGO, spoke in support of the above statement. She asked why we are still "fire fighting," that is, ignoring the root causes of why there are orphans, why women become infected. She stressed that "If you want a healthy child, then you need a healthy mother. If you sideline the mother and you think you want a healthy child, you are joking. Women have to be there to empower children." Maposhere stressed that NGOs must stand up and demand full support from funding partners and communities. Only NGOs can advocate for this, she said, because they educate civil society.

    Dr. Suniti Solomon, YRG Care, India, rebutted Maposhere's argument, stating that she "would not sacrifice the baby at any cost" if there are drugs to treat him/her. She said that 'the ideal would be to prevent women's becoming infected. But it is too late; they are already infected and that is our failure. Why should we sacrifice the baby because we cannot treat the mother? Whose choice is it to save the baby? It is the mother's choice. What mother would not want to save her baby?" She stated that India cannot afford to treat mothers. She pointed to India's extended families, which would care for orphans.

    Comments from the audience included a rebuke to Solomon's comment on the ability of the extended family to care for orphans, noting that grandparents, aunts, etc., are already having trouble coping with the impact of HIV/AIDS. UCSF's Karen Beckerman noted that in San Francisco, there was a decision early on to "deny mothers nothing." She stressed the need to effectively control maternal disease, which would thereby reduce the possibility of transmission to the infant..

    HIV/AIDS in KwaZulu-Natal

    Dr. Zweli Mkhize, KwaZulu-Natal's minister of health, provided an overview of HIV/AIDS in his province. The province, where Durban is located, is one of the hardest-hit by HIV/AIDS in South Africa. It has a population of 8.4 million; 32.5 percent of the general population is infected with HIV. (This prevalence rate is the 1999 figure for women attending antenatal clinics in the province. During that period, the comparable figure for the country as a whole was 27.4 percent.)

    A massive gender disparity was seen as the minister displayed figures on HIV prevalence among STI patients in the province. In 1999, 53.7 percent of STI patients were HIV-positive. Among female STI patients, 58.6 percent were infected with HIV during that period, whereas the comparable figure for men was 38.1 percent.

    Among black males in their 20s and 30s, the HIV prevalence rate is 21.4 to 24.4 percent. (Comparable figures for white males were not provided.)

    The minister said that South Africa's response to the epidemic had been delayed by the dismantling of apartheid in the early 1990s. He stated that the provincial AIDS budget, most of which goes to local groups, has increased dramatically. With regard to mother-to-child transmission, a guiding principle is to provide counseling to the mother. When the principles were established, there were questions about providing antiretrovirals to prevent transmission to the infant, but regardless, treatment was unaffordable. Now, with the advent of affordable interventions such as nevirapine, the minister stated that he has "concerns about resistance and that some steps in nevirapine's development were not done." After showing a slide demonstrating stagnant staffing and limited resources, the minister remarked, "If you talk about antiretroviral treatment, then you get into a crisis." Even with the discounts offered by some pharmaceuticals, he said, provision of antiretrovirals would decimate the provincial health budget.

    Minister Mkhize ended his remarks by outlining the following challenges to fighting HIV/AIDS in KwaZulu-Natal:

    • Equity; the minister posed the question, "What if we have money for ARVs but no money for clean water? How do we then treat [the resulting cases of] diarrhea?"
    • Human rights, including equality for women
    • Poverty
    • Lack of resources
    • Poor infrastructure
    • Changing attitudes

    Human Rights and the AIDS Crisis: The Debate over Resources

    Mr. Kenneth Roth, executive director, Human Rights Watch, addressed the plenary, posing the questions: Can a human rights perspective help us confront the AIDS crisis? Most important, can human rights help us meet the urgent challenge of securing the vast resources needed for treatment and prevention?

    Roth did not offer a human rights framework as a panacea to the AIDS pandemic. He stressed that it would not "magically produce the resources we need," nor point out which resources should be allocated to HIV/AIDS as opposed to addressing other societal needs. Rather, he posited that such a framework requires governments to address the crisis with appropriate urgency and transparency and facilitates transparency and a participatory policy process.

    Roth paid homage to the work of Jonathan Mann, highlighting that the new public health challenge is less what should be done to prevent or treat HIV than where do we find the enormous resources needed? Does the industrialized world have an obligation to help people from developing countries, and, if so, what precisely is it? Should obligations arising from the AIDS pandemic differ from those arising from other public health crises or from the general need for basic health care?

    Roth suggested that international human rights standards can provide a useful framework for answering these questions. The relevant standards, he notes, are not those of civil and political rights, but rather those of economic and social rights. He used the International Covenant on Economic, Social and Cultural Rights, adopted by the UN General Assembly in 1966, to develop his argument. (He also pointed out that 142 governments have ratified the covenant; South Africa and the U.S. have signed but not yet ratified it.)

    Roth began to lay out his argument by stating that a government's duty to respect economic and social rights is far more qualified than the duty to respect civil and political rights. Governments are expected to uphold the latter immediately. Moreover, responsibility for doing so lies almost exclusively with government. In contrast, economic and social rights may be fulfilled gradually, over time. The covenant states that each government is asked only to "take steps" to secure these rights and to do so only "to the maximum of its available resources, with a view to achieving progressively [their] full realization." And responsibility for compliance is broader, involving not only the government of the country at issue, but also the international community, through the duty to provide "international assistance."

    Roth demonstrated how this gradualism and shared responsibility render it much more difficult to shame a government. He explained that the tool of public shaming is most effective when there are clear answers to three basic questions:

    1. Is there a violation of human rights?
    2. Who is responsible for the violation?
    3. What is the remedy?

    When answers to all three questions are clear, public shaming can be powerful.

    In the case of HIV/AIDS, one can easily conclude that there is a violation of human rights, i.e., the right to the highest standard of health (Article 12 of the above-mentioned covenant). It is difficult, however, to answer the other two questions. So, Roth asked, how do we move beyond this impasse? He proposed that the covenant's requirement that governments "take steps" to secure economic and social rights should mean, at minimum, that they:

    1. adopt a plan that is reasonably designed to achieve the right in question, e.g., the right to adequate AIDS health care
    2. establish a timetable for implementing the plan
    3. demonstrate progress toward fulfilling the plan

    Although governments will resist these accountability measures, Roth maintains that they should spur advocacy and public shaming, as should inadequate plans and timetables and insufficient resources allocated. To hold all governments--developing and industrialized--accountable, he proposed a World Conference to Confront the AIDS Crisis. Not another talking shop, said Roth, but a venue to convene all governments in a locked room, from which no one leaves until resources adequate to an emergency are finally committed. This would also provide transparency, allowing the public to scrutinize government expenditures and priorities. It also would be a mechanism to engender solidarity.

    Roth lambasted the TRIPS agreement of the WTO (the international legal protocol for protecting patents), saying that "an industrialized government cannot be said to be 'taking steps' to 'progressively realize' the right to health when it defends excessive corporate profits over the right of access to essential, life-saving medicine." To the term "clarify excessive corporate profits," Roth contrasted "a level of corporate profits needed to provide basic incentives" with "corporate windfalls."

    Acknowledging the enormous challenge of prioritizing among competing health and HIV/AIDS-specific needs, Roth noted that human rights standards cannot provide a clear-cut roadmap for determining these priorities. They can, however, lead to transparency and thus facilitate public debate and participation.

    Roth rounded out his argument by highlighting the noneconomic dimensions of this process: governments also have a duty to provide public leadership, political will, and reliable, scientific knowledge. He went on to state:

    We must not be unsparing in our criticism of governments, like our host government, that shirk that duty, because they violate any pretence of progressively realizing the right to health in the treatment of AIDS.

    Previous Report (July 10, 2000)
    Back to Main Page

  • About | Site Map | Feedback | Subscribe | Sponsors | Donate | Disclaimer
    HIV InSite is a project of the University of California San Francisco. Copyright 2001, Regents of the University of California.